Silent plight
Our Medical Director Tim Jobson was recently featured in Pharma Times talking about why a new approach is needed for primary biliary cholangitis trials.
Read the full article here: https://pharmatimes.com/web_exclusives/silent-plight/
Our Medical Director Tim Jobson was recently featured in Pharma Times talking about why a new approach is needed for primary biliary cholangitis trials.
Read the full article here: https://pharmatimes.com/web_exclusives/silent-plight/
Introduction: Liver disease mortality in the UK has risen by more than 400% since 19701, in contrast to other common chronic diseases such as heart

hepatoSIGHT® is a case-finding system that helps clinical teams use routine historical data to identify people who may have undiagnosed progressive liver disease and could benefit from further assessment.

Recruitment to liver disease clinical trials remains one of the biggest barriers to progress.
Despite the growing burden of liver disease and the large number of studies, finding eligible participants remains a major challenge. But why?
This website uses cookies to enhance your experience. Please click accept to continue or, Click Here to find out more information.